Topical simvastatin promotes healing of staphylococcus aureus-contaminated cutaneous wounds

International Wound Journal

Volumn 13, Issue 6, 2016, Pages 1150-1157

  Wang, Chia Chi ^a   Yang, Po Wei ^a   Yang, Sheau Fang ^b,c,d   Hsieh, Kun Pin ^a   Tseng, Sung Pin ^a   Lin, Ying Chi ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b Department of Pediatrics   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Staphylococcus aureus; Statin; Topical; Wound healing

Indexed keywords

SIMVASTATIN;

ANIMAL; MOUSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WOUND HEALING; WOUND INFECTION;

ANIMALS; MICE; SIMVASTATIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

EID: 85032179165     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12431     Document Type: Article

References (36)

1. Singer AJ, Dagum AB. Current management of acute cutaneous wounds. N Engl J Med 2008;359:1037–46.
2. Wilson AP, Gibbons C, Reeves BC, Hodgson B, Liu M, Plummer D, Krukowski ZH, Bruce J, Wilson J, Pearson A. Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients. BMJ 2004;329:720.
3. O’Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2014;1:CD003557.
4. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010;3:CD006478.
5. Atiyeh BS, Dibo SA, Hayek SN. Wound cleansing, topical antiseptics and wound healing. Int Wound J 2009;6:420–30.
6. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. NEnglJMed 1996;335:1001–9.
7. Massy ZA, Keane WF, Kasiske BL. Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet 1996;347:102–3.
8. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. NEnglJMed 1995;333:1301–7.
9. Fitzmaurice GJ, McWilliams B, Nolke L, Redmond JM, McGuinness JG, O’Donnell ME. Do statins have a role in the promotion of postoperative wound healing in cardiac surgical patients? Ann Thorac Surg 2014;98:756–64.
10. Stojadinovic O, Lebrun E, Pastar I, Kirsner R, Davis SC, Tomic-Canic M. Statins as potential therapeutic agents for healing disorders. Expert Rev Dermatol 2010;5:689–98.
11. Evangelista MT, Casintahan MF, Villafuerte LL. Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 2014;170:1151–7.
12. Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother 2008;61:774–85.
13. Masadeh M, Mhaidat N, Alzoubi K, Al-Azzam S, Alnasser Z. Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. Ann Clin Microbiol Antimicrob 2012;11:13.
14. Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother 2008;61:362–4.
15. Bjorkhem-Bergman L, Lindh JD, Bergman P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol 2011;72:164–5.
16. Rego AC, Araujo Filho I, Damasceno BP, Egito ES, Silveira IA, Brandao-Neto J, Medeiros AC. Simvastatin improves the healing of infected skin wounds of rats. Acta Cir Bras 2007;22(1 Suppl):57–63.
17. Giacometti A, Cirioni O, Schimizzi AM, Del Prete MS, Barchiesi F, D’Errico MM, Petrelli E, Scalise G. Epidemiology and microbiology of surgical wound infections. J Clin Microbiol 2000;38:918–22.
18. Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. Clin Dermatol 2010;28:519–26.
19. Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 2012;20:647–57.
20. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis 2007;57:7–13.
21. Bessa LJ, Fazii P, Di Giulio M, Cellini L. Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection. Int Wound J 2015;12:47–52.
22. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, 9thCLSI publication M02-A10 edn. Clinical and Laboratory Standards Institute, 2012.
23. Cassat JE, Smeltzer MS, Lee CY. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol 2014;1085:195–211.
24. Guo Y, Ramos RI, Cho JS, Donegan NP, Cheung AL, Miller LS. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrob Agents Chemother 2013;57:855–63.
25. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004;17:91–6.
26. Daeschlein G. Antimicrobial and antiseptic strategies in wound management. Int Wound J 2013;10(1 Suppl):9–14.
27. Bergman P, Linde C, Putsep K, Pohanka A, Normark S, HenriquesNormark B, Andersson J, Bjorkhem-Bergman L. Studies on the antibacterial effects of statins – in vitro and in vivo. PLoS One 2011;6: e24394.
28. Grommes J, Vijayan S, Drechsler M, Hartwig H, Morgelin M, Dembinski R, Jacobs M, Koeppel TA, Binnebosel M, Weber C, Soehnlein O. Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One 2012;7:e38917.
29. Chow OA, von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, Cogen AL, Gallo RL, Monestier M, Wang Y, Glass CK, Nizet V. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 2010;8:445–54.
30. Asai J, Takenaka H, Hirakawa S, Sakabe J, Hagura A, Kishimoto S, Maruyama K, Kajiya K, Kinoshita S, Tokura Y, Katoh N. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol 2012;181:2217–24.
31. Bitto A, Minutoli L, Altavilla D, Polito F, Fiumara T, Marini H, Galeano M, Calo M, Lo Cascio P, Bonaiuto M, Migliorato A, Caputi AP, Squadrito F. Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. Pharmacol Res 2008;57:159–69.
32. Vukelic S, Stojadinovic O, Pastar I, Vouthounis C, Krzyzanowska A, Das S, Samuels HH, Tomic-Canic M. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. JBiolChem2010;285:1980–8.
33. Adami M, Prudente Ada S, Mendes DA, Horinouchi CD, Cabrini DA, Otuki MF. Simvastatin ointment, a new treatment for skin inflammatory conditions. J Dermatol Sci 2012;66:127–35.
34. Farsaei S, Khalili H, Farboud ES. Potential role of statins on wound healing: review of the literature. Int Wound J 2012;9:238–47.
35. Feingold KR, Man MQ, Proksch E, Menon GK, Brown BE, Elias PM. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia. J Invest Dermatol 1991;96:201–9.
36. Zhu XY, Daghini E, Chade AR, Lavi R, Napoli C, Lerman A, Lerman LO. Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci 2008;83:801–9.